ReviewTheranostics2023
PRL3 as a therapeutic target for novel cancer immunotherapy in multiple cancer types.
Pei Ling Chia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papertrialcites it
ReviewTheranostics2023
Pei Ling Chia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.